Cancer screening not needed with vasculitis Dx.(Across Specialties)

By Bruce Jancin   |   Skin & Allergy News  –  Oct, 2008 

“The overall message of our study is that as a clinician you don’t have to screen your patients with newly diagnosed [anti-neutrophil cytoplasmic antibody (ANCA)–associated vasculitis] for any underlying cancer on a routine basis,” Dr. Mikkel Faurschou said at the annual congress of the European League Against Rheumatism. 

See the rest of the article here.

What I have to say: It is very interesting that clinicians don’t think ANCA Vasculitis patients need cancer screening. In my experience, there has been kidney cancer from WG patients after using cychlophosphamide. Plus I had a breast tumor that turned out to be benign, while I was taking WG treatment. So there are cases of cancer that do happen to Vasculitis patients. We can be grateful that it is not as common across the Vasculitis spectrum.

Advertisements

About Cyn Bagley

My life is a mixture of travel, jobs, and disease. You can find some of my novels on amazon.com under the name Cyn Bagley.
This entry was posted in cancer, cytoxan, treatment, Vasculitis. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s